From: Risk factors for postoperative ileus after diverting loop ileostomy closure
Total (n = 68) | POI (+) (n = 11) | POI (−) (n = 57) | p value | |
---|---|---|---|---|
Age (years) | 64.4 ± 10.0 | 69.5 ± 7.7 | 63.4 ± 10.3 | 0.065 |
Sex (Male/Female) | 48/20 | 9/2 | 39/18 | 0.487 |
ASA-PS (I/II/III) | 24/37/7 | 3/6/2 | 21/31/5 | 0.636 |
BMI | 22.7 ± 3.4 | 23.0 ± 2.3 | 22.6 ± 3.6 | 0.735 |
Cancer | ||||
Rotation (Rs/Ra/Rb) | 17/20/31 | 14/24/19 | 3/1/7 | 0.235 |
Stage (0/I/II/III/IV/X/others) | 1/27/17/15/5/1/2 | 1/6/2/0/1/0/1 | 0/21/15/15/4/1/1 | 0.068 |
Index surgery | ||||
Laparoscopic operative procedure (AR/ISR/TC/TAMIS) | 45/20/2/1 | 6/3/1/1 | 39/17/1/0 | 0.113 |
TaTME | 36 (52.9%) | 6 (54%) | 30 (52.6%) | 1.000 |
LLND | 15 (22.1%) | 2 (18.2%) | 13 (22.8%) | 1.000 |
Operating time (min) | 352.6 ± 116.4 | 383.7 ± 144.4 | 346.6 ± 111,8 | 0.341 |
Blood loss (ml) | 61.4 ± 75.9 | 69.9 ± 63.2 | 60.0 ± 79.2 | 0.726 |
Complication (Clavien–Dindo grade ≥ III) | 5 (7.4%) | 3 (27.3%) | 2 (3.5%) | 0.022 |
Ileus | 2 (2.9%) | 1 (9.1%) | 1 (1.8%) | 0.299 |
Anastomotic stenosis | 2 (2.9%) | 1 (9.1%) | 1 (1.8%) | 0.299 |
Neurogenic bladder | 1 (1.5%) | 1 (9.1%) | 0 (0%) | 0.169 |
Neoadjuvant radiotherapy | 4 (5.9%) | 1 (9.1%) | 3 (5.3%) | 0.515 |
Neoadjuvant chemotherapy (Yes/No) | 15 (22.1%) | 1 (9.1%) | 14 (24.6%) | 0.433 |
Adjuvant chemotherapy (Yes/No) | 20 (29.4%) | 0 (0%) | 20 (35.1%) | 0.026 |
Interval between the index surgery and ileostomy closure (days) | 183.5 ± 125.3 | 143.9 ± 28.8 | 192.8 ± 135.5 | 0.165 |
Ileostomy closure | ||||
Anastomosis (end-to-end/side-to-side) | 62/6 | 11/0 | 51/6 | 0.579 |
Skin closure (purse string/linear) | 64/4 | 11/0 | 53/4 | 1.000 |
Operating time (min) | 94.0 ± 24.3 | 98.7 ± 14.1 | 93.1 ± 26.0 | 0.488 |
Blood loss (ml) | 12.3 ± 22.1 | 6.4 ± 8.7 | 13.5 ± 23.8 | 0.334 |
Complication | 16 (22.1%) | |||
Ileus | 11 (16.2%) | 11 (100%) | NA | NA |
Clavien–Dindo grade I | 2 (18.2%) | 2 (18.2%) | NA | NA |
Clavien–Dindo grade II | 3 (27.3%) | 3 (27.3%) | NA | NA |
Clavien–Dindo grade IIIa | 5 (45.4%) | 5 (45.4%) | NA | NA |
Clavien–Dindo grade IIIb | 1 (9.1%) | 1 (9.1%) | NA | NA |
Duration of treatment (days) | 7.9 ± 4.5 | 7.9 ± 4.5 | NA | NA |
Other | 5 (7.4%) | 1 (9.1%) | 4 (7.0%) | 0.813 |
Food intake after surgery (days) | 6.5 ± 5.2 | 12.4 ± 5.0 | 5.4 ± 4.5 | > 0.001 |
Hosptal stay after surgery (days) | 11.9 ± 4.2 | 18.5 ± 5.6 | 10.6 ± 2.5 | > 0.001 |